Uscom Ltd
UCM.AU
$0.02
Closing
0.00
1D
▼-24.39%
YTD
Market cap
$4.93M
52 week high
$0.04
52 week low
$0.01
Volume
16,000
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $3.99/month
Market cap
$4.93M
Analysts' Rating
-
Price Target (Mean)
-
Total Analysts
0
P/E
Operating Margin
-77.24%
Beta
-0.70
Revenue Growth (Annual)
-3.25%
52 week high
$0.04
52 week low
$0.01
Div. Yield
%
EPS Annual Growth
0.00
Note on Purification and Zakat
- Purification and Zakat (for long-term investing) calculations are in USD per share and based on AAOIFI methodology. AAOIFI requires purification every financial period (e.g. quarterly).
- If you follow S&P Shariah’s Dividend-only purification, then remove the impure income % from the dividends you receive. No purification required for non-dividend paying stocks, according to S&P Shariah.
- For Zakat, if you did not invest in a company from a long term perspective, then consider the shares as trading goods and give 2.5% of the total value if a year has passed on them.
Company Profile
Uscom Limited is an Australia-based medical technology company that specializes in the development and marketing of non-invasive cardiovascular and pulmonary medical devices. The Company sells two cardiovascular products, the USCOM 1A cardiac output monitor and the Uscom BP+ central blood pressure monitor and a series of pulmonary products, the Uscom SpiroSonic spirometers. The USCOM 1A is a non-invasive advanced hemodynamic monitor that measures cardiovascular function using Doppler ultrasound to detect abnormalities and guide treatment. The BP+ is a supra-systolic oscillometric central blood pressure monitor, which measures blood pressure and blood pressure waveforms at the heart, as well as in the arm. Uscom SpiroSonic digital ultrasonic spirometers are digital, pulmonary function testing devices based on multi-path ultrasound technology. It has geographic sales and distribution segments, which include Australia, Asia, the Americas and Europe.
